JP2024510778A5 - - Google Patents
Info
- Publication number
- JP2024510778A5 JP2024510778A5 JP2023558324A JP2023558324A JP2024510778A5 JP 2024510778 A5 JP2024510778 A5 JP 2024510778A5 JP 2023558324 A JP2023558324 A JP 2023558324A JP 2023558324 A JP2023558324 A JP 2023558324A JP 2024510778 A5 JP2024510778 A5 JP 2024510778A5
- Authority
- JP
- Japan
- Prior art keywords
- independently selected
- alkyl
- corneal
- pharmaceutically acceptable
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163166289P | 2021-03-26 | 2021-03-26 | |
| US63/166,289 | 2021-03-26 | ||
| PCT/IB2022/052720 WO2022201097A1 (en) | 2021-03-26 | 2022-03-24 | 1,3-substituted cyclobutyl derivatives and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024510778A JP2024510778A (ja) | 2024-03-11 |
| JP2024510778A5 true JP2024510778A5 (enExample) | 2026-05-19 |
| JP7887908B2 JP7887908B2 (ja) | 2026-07-10 |
Family
ID=80999265
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023558324A Active JP7887908B2 (ja) | 2021-03-26 | 2022-03-24 | １，３－置換シクロブチル誘導体及びその使用 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US11845730B2 (enExample) |
| EP (1) | EP4313951A1 (enExample) |
| JP (1) | JP7887908B2 (enExample) |
| KR (1) | KR20230162660A (enExample) |
| CN (1) | CN117062804A (enExample) |
| AR (1) | AR125196A1 (enExample) |
| AU (1) | AU2022244467A1 (enExample) |
| CA (1) | CA3214066A1 (enExample) |
| IL (1) | IL307189B1 (enExample) |
| MX (1) | MX2023011377A (enExample) |
| PY (1) | PY2221203A (enExample) |
| TW (1) | TWI924820B (enExample) |
| UY (1) | UY39681A (enExample) |
| WO (1) | WO2022201097A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR125196A1 (es) * | 2021-03-26 | 2023-06-21 | Novartis Ag | Derivados de ciclobutilo 1,3-sustituidos y sus usos |
| JP2025531367A (ja) * | 2022-09-21 | 2025-09-19 | ボシュ ＋ ロム アイルランド リミテッド | Ｔｒｐｖ１アンタゴニストの結晶多形形態およびその製剤 |
| US20240148709A1 (en) * | 2022-11-08 | 2024-05-09 | Aisa Pharma, Inc. | Methods of treating eye pain and eye disorders |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004078163A2 (en) | 2003-02-28 | 2004-09-16 | Transform Pharmaceuticals, Inc. | Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen |
| US6933311B2 (en) | 2003-02-11 | 2005-08-23 | Abbott Laboratories | Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor |
| US7514562B2 (en) | 2003-03-07 | 2009-04-07 | Glaxo Group Limited | Urea derivatives and their use as vanilloid receptor antagonists in the treatment of pain |
| GB0412769D0 (en) | 2004-06-08 | 2004-07-07 | Novartis Ag | Organic compounds |
| RU2451014C2 (ru) | 2005-07-22 | 2012-05-20 | Мотида Фармасьютикал Ко., Лтд. | Новое производное гетероциклиден ацетамида |
| KR20090031898A (ko) * | 2006-07-13 | 2009-03-30 | 교와 핫꼬 기린 가부시키가이샤 | 펜타디엔아미드 유도체 |
| CN101595094B (zh) | 2006-12-27 | 2013-02-20 | 塞诺菲-安万特股份有限公司 | 环烷基胺取代的异喹诺酮衍生物 |
| WO2012072512A1 (en) * | 2010-11-29 | 2012-06-07 | Glaxo Group Limited | N-cyclobutyl-imidazopyridine or -pyrazolopyridine carboxamides as trpv1 antagonists |
| DE102010052781A1 (de) * | 2010-11-30 | 2012-05-31 | Trw Automotive Gmbh | Befestigungsvorrichtung und Befestigungsbaugruppe zur Befestigung eines Gasgenerators und Fahrzeuginsassenrückhaltesystem |
| WO2012134943A1 (en) | 2011-03-25 | 2012-10-04 | Abbott Laboratories | Trpv1 antagonists |
| US8754101B2 (en) | 2011-04-11 | 2014-06-17 | Glaxo Group Limited | N-cyclobutyl-imidazopyridine-methylamine as TRPV1 antagonists |
| WO2017079162A1 (en) | 2015-11-02 | 2017-05-11 | Castar, Inc | Method of immersive rendering for wide field of view |
| US10269906B2 (en) * | 2016-11-30 | 2019-04-23 | Taiwan Semiconductor Manufacturing Co., Ltd. | Semiconductor device having two spacers |
| WO2018151678A1 (en) | 2017-02-15 | 2018-08-23 | Agency For Science, Technology And Research | Compounds for treatment of cancer and epigenetics |
| US11542248B2 (en) | 2017-06-08 | 2023-01-03 | Kura Oncology, Inc. | Methods and compositions for inhibiting the interaction of menin with MLL proteins |
| JP7594787B2 (ja) | 2018-12-07 | 2024-12-05 | ユニバーシティ オブ メリーランド、ボルチモア | 非ＡＴＰ／触媒部位ｐ３８マイトジェン活性化プロテインキナーゼ阻害剤 |
| AR125196A1 (es) * | 2021-03-26 | 2023-06-21 | Novartis Ag | Derivados de ciclobutilo 1,3-sustituidos y sus usos |
-
2022
- 2022-03-22 AR ARP220100676A patent/AR125196A1/es unknown
- 2022-03-22 UY UY0001039681A patent/UY39681A/es unknown
- 2022-03-23 PY PY202202221203A patent/PY2221203A/es unknown
- 2022-03-24 CN CN202280024266.2A patent/CN117062804A/zh active Pending
- 2022-03-24 WO PCT/IB2022/052720 patent/WO2022201097A1/en not_active Ceased
- 2022-03-24 KR KR1020237036535A patent/KR20230162660A/ko active Pending
- 2022-03-24 US US17/656,313 patent/US11845730B2/en active Active
- 2022-03-24 EP EP22714016.7A patent/EP4313951A1/en active Pending
- 2022-03-24 TW TW111111060A patent/TWI924820B/zh active
- 2022-03-24 AU AU2022244467A patent/AU2022244467A1/en active Pending
- 2022-03-24 CA CA3214066A patent/CA3214066A1/en active Pending
- 2022-03-24 JP JP2023558324A patent/JP7887908B2/ja active Active
- 2022-03-24 IL IL307189A patent/IL307189B1/en unknown
- 2022-03-24 MX MX2023011377A patent/MX2023011377A/es unknown
-
2023
- 2023-10-24 US US18/493,441 patent/US12435040B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107172879B (zh) | 抗白细胞介素-33抗体及其用途 | |
| JP2017514917A5 (enExample) | ||
| CN110662752B (zh) | 用于临床管理由衰老细胞引起或介导的病症以及治疗癌症的Bcl家族拮抗剂磷杂环化合物 | |
| JP2023100864A (ja) | 老化細胞を排除する薬学的作用物質を用いる、黄斑変性症、緑内障、および糖尿病性網膜症などの眼病態の治療 | |
| RU2014123472A (ru) | Производные 4-прегенен-11ss-17-21-триол-3,20-диона для лечения глазных болезней | |
| JP2022507404A5 (enExample) | ||
| US20210113529A1 (en) | Medicine for preventing or treating ophthalmic disease associated with enhanced intraocular neovascularization and/or intraocular vascular permeability | |
| CN101484004A (zh) | 新型大麻素及使用方法 | |
| JP2022520832A5 (enExample) | ||
| RU2424795C2 (ru) | Лечение аутоиммунных заболеваний | |
| TW201927298A (zh) | 賽佩普斯特（Ｓｅｐｅｔａｐｒｏｓｔ）及Ｒｈｏ激酶抑制劑之組合醫藥 | |
| JP2015160826A (ja) | ジクアホソルまたはその塩およびレバミピドまたはその塩を組み合わせたことを特徴とする涙液分泌促進剤 | |
| TW202131914A (zh) | 用於神經疾病或病狀的治療之新治療方案 | |
| CA3037116A1 (en) | Methods for treating ocular disease using inhibitors of csf-1r | |
| JP5955774B2 (ja) | プロスタグランジンアゴニストのプロドラッグの安定した水性組成物およびその使用方法 | |
| US20230285411A1 (en) | Drug formulation containing sepetaprost | |
| US11576914B2 (en) | Drug for treating or preventing disorder caused by TGF-β signaling, and application thereof | |
| WO2021145355A1 (ja) | 近視の治療、近視の予防および／または近視の進行抑制のための医薬組成物 | |
| JP2022152866A (ja) | コール酸またはコール酸誘導体を含有する老視の治療または予防剤 | |
| JP2004123716A (ja) | 化学物質に起因する肝障害の予防及び／又は治療のための医薬 | |
| CA3092815A1 (en) | Use of n-4-(hydroxycarbamoyl)benzyl derivatives in the treatment and prevention of dry eye | |
| RU2021126673A (ru) | Способы лечения боли на поверхности глаза | |
| JP7429500B2 (ja) | 角膜上皮障害治療剤 | |
| EP4686472A1 (en) | Cxcl8 inhibitors for use in the treatment of ocular graft-versus-host disease | |
| TW202210066A (zh) | 對老花眼之治療或預防有用之含硫化合物 |